Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Highlights

Highlights

CMAJ August 26, 2008 179 (5) 393;
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
  • © 2008 Canadian Medical Association

Stopping anticoagulants after unprovoked thromboembolism

Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of treatment following a first unprovoked venous thromboembolism. This is the conclusion reached by Rodger and colleagues, whose multicentre prospective cohort study included 646 participants. The risk factors were hyperpigmentation, edema or redness of either leg, D-dimer ≥ 250 μg/L, a body mass index ≥ 30 kg/m2 and age ≥ 65 years. See Research, page 417

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Photo by: Visuals Unlimited/Corbis

In an accompanying commentary, Kearon says that the preference of patients, after the risks and benefits of treatment have been explained to them, should also influence the duration of treatment. See Commentary, page 401

Cholesterol, cancer and diabetes

Both low and high levels of low-density lipoprotein (LDL) cholesterol are associated with an increased risk of cancer among patients with type 2 diabetes. Yang and colleagues discovered this V-shaped association in the subgroup of 3800 patients with diabetes who were not taking statins. See Research, page 427

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Hazard ratios (and 95% confidence intervals) for low-density lipoprotein cholesterol levels associated with cancer among patients with diabetes who did not use statins.

Confounding factors such as indication for use of statins, lifestyle factors and socioeconomic status need to be considered when we look at the association between high levels of LDL cholesterol and the risk of cancer, say Ding and Hu in a related commentary. See Commentary, page 403

Warnings of serious adverse events

Regulatory warnings slowed the growth of the use of atypical antipsychotic drugs among elderly patients with dementia, but they did not reduce the overall prescription rate of these drugs. Valiyeva and colleagues came to this conclusion from their analysis of prescription claims data of atypical and conventional antipsychotic drugs before and after 3 regulatory warnings had been issued. The authors call for more effective interventions to improve postmarket drug safety. See Research, page 438

Some health care warnings fail to achieve the desired effect because they have not provided physicians with information about the effectiveness and safety of alternative treatment options, says Katz in a related commentary. See Commentary, page 405

Colour of eyes

Read about a 35-year-old woman with 2 different eye colours and miosis in her left eye in our Teaching case. See Practice, page 447

Colour of urine

What is the cause of purple-coloured urine in a 58-year-old man with an indwelling catheter? See Clinical images, page 491

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Patient safety

The patient safety movement may provide the rationale and justification for a no-fault compensation system. See News, page 407

Safety of prescription drugs

Health Canada is investing $1 million in an independent research network to study the safety of prescription drugs. Is it enough? See News, page 412

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 179 (5)
CMAJ
Vol. 179, Issue 5
26 Aug 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Highlights
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights
CMAJ Aug 2008, 179 (5) 393;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Highlights
CMAJ Aug 2008, 179 (5) 393;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
  • Stopping anticoagulant therapy after an unprovoked venous thromboembolism
  • Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
  • Cancer and cholesterol: understanding the V-shaped association in patients with diabetes
  • Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis
  • Concerns about health care warnings and their impact on prescribing behaviour
  • Heterochromia
  • Purple urine bag syndrome
  • Fault/no fault part 2: uneasy bedfellows
  • Health Canada's investment in new post-market drug surveillance network a “pittance”
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlights
  • Highlights
  • Highlights
Show more Highlights

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire